Signatures guide drug choice

Julian Downward ()
Additional contact information
Julian Downward: the Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields

Nature, 2006, vol. 439, issue 7074, 274-275

Abstract: Cancer drugs are increasingly designed to target specific cell-signalling pathways. When, and in what combination, these drugs should be used might be judged by analysing the gene expression signature of the tumour.

Date: 2006
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/439274a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:439:y:2006:i:7074:d:10.1038_439274a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/439274a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().